PPIs, C. diff, and the Infection Question

Do PPIs raise the risk of infection?

Yes, in a limited and specific sense: observational studies have linked long-term PPI use to a higher rate of certain infections, most consistently C. difficile and some enteric and respiratory infections, though how much of that risk is truly caused by the drug, rather than by whatever led someone to need it, remains unsettled. An expert review of long-term ppi safety looked at this alongside other purported harms and found the evidence too limited to justify routine changes in care for patients who have a genuine reason to be on the medication 1Ref 1Freedberg DE, Kim LS, Yang YX (2017).The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.Supports the AGA's long-term PPI risk/benefit review, which weighed infection risk among other purported harms and found insufficient evidence to justify routine changes for appropriately indicated patients..

That's a narrower finding than 'PPIs are dangerous' or 'PPIs are perfectly safe.' It's closer to: a plausible, modest signal exists in the data, professional guidance has looked at it directly, and the answer for most people who need acid suppression is not to stop, but to use the lowest dose that controls the underlying condition.

The people studied in this research are also rarely a clean comparison group. Someone on a long-term PPI is often older, has been hospitalized more often, or takes other medications that independently raise infection risk — any of which could explain part of an observed association without the PPI itself doing anything. Separating those threads apart is exactly the kind of work an expert review is built to do, rather than a single headline-generating study.

Why suppressing stomach acid could plausibly raise infection risk

Stomach acid is one of the body's basic defenses against ingested bacteria — it's acidic enough to kill many organisms before they ever reach the intestine, and reducing that acidity for years is a reasonable mechanism by which some infections could become somewhat more likely. That plausibility is exactly why researchers have looked for the effect in the first place, and exactly why finding a plausible mechanism is not the same as proving it's a large or clinically meaningful effect at the doses and durations most patients actually use.

C. difficile spores, in particular, tolerate a normal stomach's acidity poorly, which is the leading theoretical explanation offered for why this specific infection comes up most often in this conversation. That mechanism is strongest in people who are already at elevated risk for other reasons — recent antibiotic use, a hospital stay, or a weakened immune system — rather than in an otherwise healthy person taking a PPI for ordinary reflux, which is exactly the distinction that gets lost when the concern is summarized as a single blanket warning.

What the AGA's review of long-term PPI safety concluded

The same expert review that examined ppis and kidney disease, ppis and bone loss, and ppis and nutrient levels also weighed the infection question, and reached a consistent verdict across all of them: the benefits of an appropriately indicated PPI generally outweigh these purported risks, and there isn't strong enough evidence to justify routine strategies aimed at preventing them 1Ref 1Freedberg DE, Kim LS, Yang YX (2017).The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.Supports the AGA's long-term PPI risk/benefit review, which weighed infection risk among other purported harms and found insufficient evidence to justify routine changes for appropriately indicated patients..

No professional guideline recommends avoiding a needed PPI purely because of infection risk. The practical guidance is the same across every purported harm reviewed: use the lowest effective dose, and periodically revisit whether the original reason for taking it still applies 1Ref 1Freedberg DE, Kim LS, Yang YX (2017).The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.Supports the AGA's long-term PPI risk/benefit review, which weighed infection risk among other purported harms and found insufficient evidence to justify routine changes for appropriately indicated patients..

Untangling this from H. pylori, a different kind of stomach infection

H. pylori is an actual bacterial infection of the stomach lining, and it's the most common identifiable cause of gastritis — a completely separate question from whether a PPI itself raises infection risk 2Ref 2National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2019).Symptoms & Causes of Gastritis & Gastropathy.Supports that H. pylori infection is the most common identifiable cause of gastritis, distinct from any PPI-related infection-risk question.. Someone can carry an H. pylori infection whether or not they've ever taken a PPI, and treating it requires a course of antibiotics aimed at the bacterium itself, not a change in acid-suppressing medication 3Ref 3Chey WD, Howden CW, Moss SF, Morgan DR, Greer KB, Grover S, Shah SC (2024).ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.Supports that H. pylori is a bacterial infection treated with a dedicated antibiotic regimen, unrelated to PPI use itself..

The two questions get confused because both involve the word 'infection' and both involve the stomach, but they don't answer to each other. Eradicating H. pylori doesn't address the theoretical PPI-and-C.-diff concern, and stopping a PPI doesn't treat an H. pylori infection — they're managed on entirely separate tracks.

Current guidance for H. pylori itself has also shifted: rising resistance to older antibiotic regimens has pushed treatment toward bismuth quadruple therapy as a preferred first-line option, with confirmation testing afterward to make sure the infection actually cleared 3Ref 3Chey WD, Howden CW, Moss SF, Morgan DR, Greer KB, Grover S, Shah SC (2024).ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.Supports that H. pylori is a bacterial infection treated with a dedicated antibiotic regimen, unrelated to PPI use itself.. None of that treatment decision has anything to do with whether the person is also taking a PPI for an unrelated reflux problem, and confirming eradication afterward matters regardless of what other medications are involved.

Who should reconsider a long-term PPI, and who has a clear reason to continue

Patients with a documented indication — erosive esophagitis, Barrett's esophagus, or a history of bleeding ulcers — generally have more to lose by stopping than by any purported infection risk, and continuing treatment is the recommended path for them 4Ref 4Targownik LE, Fisher DA, Saini SD (2022).AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review.Supports which patients should continue a PPI versus attempt to step down or stop under clinical guidance.. For patients without a clear ongoing indication, the same guidance recommends attempting to step down or stop under a clinician's supervision, rather than continuing indefinitely by default.

Tapering off a ppi has its own considerations — rebound acid production is real and can feel like the original problem returning — which is part of why stopping is generally planned rather than done abruptly in response to a single worrying article.

What actually changes the calculation

A history of recurrent, severe diarrhea — especially one that developed after a hospital stay or a course of antibiotics — is worth mentioning to a clinician regardless of PPI use, because that pattern has its own evaluation separate from any theoretical medication risk. It's a symptom pattern, not a PPI side effect assumption, that should prompt a call.

Reporting new or unusual symptoms honestly gives a clinician the information needed to weigh continuing, adjusting, or stopping a PPI against the specific reasons it was started, rather than against a generic worry about ppis and dementia or any other headline-driven concern circulating at the same time.